Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Allen, Michael H
SLC-0111-17-01, NCT03450018: A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX	Terminated	1/2	6	Canada	SLC-0111, WBI-5111, Gemcitabine Injection, Gemcitabine	British Columbia Cancer Agency, Canadian Cancer Society (CCS), SignalChem Lifesciences Corporation	Metastatic Pancreatic Ductal Adenocarcinoma	05/24	05/24
NCT04488367: Blood Loss After Early TXA in Hip Fractures.	Recruiting	1	120	US	Tranexamic acid, Early TXA, Normal Saline, Control Placebo	Community Memorial Health System	Hip Fractures	07/23	07/23